Purinergic P2X7 receptor: A pivotal role in inflammation and immunomodulation

Drug Development Research

Volumn 45, Issue 3-4, 1998, Pages 207-213

  Virgilio, Francesco Di ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

ATP; Inflammation; Purinergic receptors

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINE P2X RECEPTOR;

CONFERENCE PAPER; DRUG TARGETING; IMMUNOMODULATION; INFLAMMATION; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY;

EID: 0032452987     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2299(199811/12)45:3/4<207::aid-ddr18>3.0.co;2-n     Document Type: Conference Paper

References (59)

1. Abraham EH, Pratt AG, Genveck L, Seneveratne T, Arceci TJ, Kramer R, Guidotti G, Cantiello HE 1993. The multidmg resistance (mdrl) gene product functions as an ATP channel. Proc Natl Acad Sei USA 90:312-316.
2. Abraham EH, Vos P, Kahn J, Grubman SA, Jefferson DM, Ding I, Okunieff PR 1996. Cystic fibrosis hetero and homozygosity associated with inhibition of breast cancer growth. Nat Med 2:593-596.
3. Abraham EH, Okunieff P, Scala S, Vos R Oosterveld MJS, Chen AY, Shrivastav B, Reddy MM, Quinton PM, Grygorczyk R, Tabcharani JA, Hanrahan J\V, Gunderson KL, Kopito RR. 1997. Cystic fibrosis transrnembrane conductance regulator and adenosine triphosphate. Science 275:1324-1326.
4. Baricordi OR, Ferrari D, Melchiorri L, Chiozzi R Hanau S, Chiari E, Rubini M, Di Virgilio E 1996. Au ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87:682-690.
5. Blanchard DK, McMillen S, Djeu JY. 1991. IFN-y enhances sensitivity of human macrophages to extracellular ATP-mediated lysis. J Immunol 147:2579-2585.
6. Bretschneidcr F, Klapperstuck M, Lohn M, Markwardt E 1995. Nonselective cation currents elicited by extracellular ATP in human B lymphocytes. Pfluegers Arch Eur J Physiol 429:691-698.
7. Buell G, Chessel IR Michel AECollo G, Salazzo M, Herren S, Gretner D, Grahames C, Kaur R, Kosco-Vilbois MH, Humphrey PPA. 1998. Blockade of human P2X7 receptor function with a monoclonal antibody. Blood 92:3251-3258.
8. Burnstock G. 1997. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36:1127-1139.
9. Cario-Toumaniantz C, Loirand G, Ladoux A, Pacaud E 1998. P2X7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res 83:196-203.
10. Chiozzi P, Sanz JM, Ferrari D, Falzoni S, Aleotti A, Buell GN, Collo G, Di Virgilio E 1997. Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2Xy receptor. J Cell Biol 138:697-706.
11. Chused TM, Apasov S, Sitkovsky M. 1996. Murine T lymphocytes modulate activity of an ATP-activated P2Z-type purinoceptor during differentiation. J Immunol 157:1371-1380.
12. Cockcroft S, Gomperts BD. 1979. ATP induces nucleotide permeability in rat mast cells. Nature 279:451-452.
13. Cohn ZA, Parks E. 1967. The regulation of pinocytosis in mouse macrophages: III. The induction of vesicle formation by nucleosides and nucleotides. J Exp Med 125:457-166.
14. Collo G, Neidhart S, Kawashima E, Kosco-Vilbois M, North RA, Buell G. 1997. Tissue distribution of the P2Xy receptor. Neuropharmacology 36:1277-1283.
15. Cote YP, Picher M, Stjean E Beliveau R, Potier M, Beaudoin AR. 1991. Identification and localization of ATP-diphosphohydrolase (apyrase) in bovine aorta-relevance to vascular tone and platelet aggregation. Biochim Biophys Acta 1078:187-191.
16. Di Virgilio E 1995. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today 16:524-528.
17. Di Virgilio E Bronte V, Collavo D, Zanovello E19S9. Responses of mouse lymphocytes to extracellular adenosine 5'-triphosphate (ATP): lymphocytes \vith cytotoxic activity are resistant to the permeabilizing effect of ATE J Immunol 143:1955-1960.
18. Di \7irgilio E Sanz JM, Chiozzi E Falzoni S. 1999. The P2Z/P2X7 receptor of microglial cells: a novel immunomodulatory receptor. Prog Brain Res (in press).
19. Dubyak GR, Clifford EE, Humphreys BD, Kertesy SB, Martin KA. 1996. Expression of multiple ATP receptor subtypes during the differentiation and inflammatory activation of myeloid leukocytes. Drug Dev Res 39:269-278.
20. Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S, Di Virgilio E 1995. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 95:1207-1216.
21. Ferrari D, Munerati M, Melchiorri L, Hanau S, Di Virgilio F, Baricordi OR. 1994. Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients. Am J Physiol 267:C886-CS92.
22. Ferrari D, Mllalba M, Chiozzi E Falzoni S, Ricciardi-Castagnoli E Di Virgilio E 1996. Mouse microglial cells express a plasma membrane pore gated by extracellular ATE J Immunol 156:1531-1539.
23. Ferrari D, Chiozzi E Falzoni S, Dal Susino M, Collo G, Buell GN, Di Virgilio E 1997a. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36:1295-1301.
24. Ferrari D, Chiozzi E Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio E 1997b. Extracellular ATP triggers IL-lß release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159:1451-1458.
25. Ferrari D, Chiozzi E Falzoni S, Hanau S, Di Virgilio E 1997. Purinergic modulation of interleukin-lß release from microglial cells stimulated with bacterial endotoxin. J Exp Med 185:579-582.
26. Filippini A, Taffs R, Sitkovsky MV. 1990. Extracellular ATP in T-lym-phocyte activation: possible role in effector functions. Proc Natl Acad USA 87:8267-8271.
27. Flens MJ, Zaman GJ, van der Valk P, Izquierdo MA, Schroeijers AB, Scheffcr GL, van der Groep P, de Haas M, Meijer CI, Scheper RJ. 1996. Am J Pathol 148:1237-1247.
28. Gargett CE, Wiley JS. 1997. The isoquinoline derivative KN-62: a potent antagonist of the P2Z receptor of human lymphocytes. Br J Phannacol 120:1483-1490.
29. Girolomoni G, Santantonio ML, Pastore S, Bengstresser PR, Giannetti A, Cruz PC. 1993. Epidermal Langerhans cells are resistant to the permeabilizing effect of extracellular ATP: In vivo evidence supporting a protective role of membrane ATPases. J Invest Dermatol 100:282-290.
30. Gordon JL. 1990. The effects of ATP on endothelium. Ann NY Acad Sei 603:46-52.
31. Gu B, Bendall LJ, Wiley JS. 1998. Adenosine triphosphate-induced shedding of CD23 and L-seleetin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood (in press).
32. Jamieson GP, Snook MB, Thurlow PJ, Wiley JS. 1996. Extracellular ATP causes loss of L-selectin from human lymphocytes via occupancy of P2Z purinoceptors. J Cell Physio! 166:637-642.
33. Hassessian H, Bodin P, Bumstock G. 1993. Blockade by glibenclamide of the flow-evoked endothelial release of ATP that contributes to the vasodilatation in the pulmonary bed of the rat. Br J Pharmacol 109:466-472.
34. Hickman SE, El Khoury J, Greenberg S, Schieren I, Silverstein SC. 1994. P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. Blood 84:2452-2456.
35. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. 1991. Interleukin1 is processed and released during apoptosis. Proc Natl Acad Sei USA 88:8445-8450.
36. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC. 1996. Identification and characterization of CD39/vascuIar ATP diphosphohydrolase. J Biol Chem 271:33116-33122.
37. Kansas GS, Wood GS, Tedder TE 1991. Expression, distribution, and biochemistr)' of human CD39: role in activation-associated homotypic adhesion of lymphocytes. J Immunol 146:2235-2244.
38. Kegel B, Braun N, Heine P, Maliszewski CR, Zimmermann H. 1997. An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology 36:1189-1200.
39. Lammas DA, Stober C, Harvey CJ, Kendrick N, Panchalingam S, Kumararatne DS. 1997. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7:433-444.
40. Ludescher C, Pall G, Irschick EU, Gastl G. 199S. Differential activity of P-glycoprotein in normal blood lymphocyte subsets. Br J Haematol 101:722-727.
41. Molloy A, Laochumroonvorapong P, Kaplan G. 1994. Apoptosis but not necrosis of infected monocytes is coupled with killing of intracellular BCG. J Exp Med 180:1499-1509.
42. Monck JR, Femandez JM. 1996. The fusion pore and mechanisms of biological membrane fusion. Curr Opin Cell Biol 8:524-533.
43. Morabito L, Montesinos MC, Schreibman DM, Balter L, Thompson L, Resta R, Carlin G, Ikile A, Cronstein BN. 1998. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 101:295-300.
44. Murgia M, Hanau S, Pizzo P, Rippa M, Di Virgilio E 1993. Oxidised ATP: an irreversible inhibitor of the macrophage P2Z receptor. J Biol Chem 268:8199-8203.
45. Pearson JD, Gordon JL. 1979. Vascular endothelium and smooth muscle cells in culture selectively release adenine nucleotides. Nature 281:384-386.
46. Perregaux D, Gabel CA. 1994. Interleiikin-lb maturation and release in response to ATP and nigérian. J Biol Chem 260:15195-15203.
47. Perregaux DG, Gabel CA. 1998. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-lct and IL-lß occurs via a similar mechanism. J Immunol 160:3469-2477.
48. Pizzo P, Zanovello P, Bronte V, Di Virgilio E 1991. Extracellular ATP causes lysis of mouse lymphocytes and activates a plasma membrane ion channel. Biochem J 274:139-144.
49. Rassendren E Buell GN, N'irginio C, Collo G, North RA, Surprenant A. 1997. The permeabilizing ATP receptor P2Xy: cloning of a human cDNA. J Biol Chem 272:5482-5486.
50. Reisin IL, Prat AG, Abraham EH, Aniara JE Gregory- RJ, Ausiello DA, Cantiello HE 1994. The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J Biol Chem 269:20584-20591.
51. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH. 1997. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 185:153-163.
52. Roman RM, Wang Y, Lidofsky SD, Feranchak AP, Lomri N, Scharschmidt BF, Fitz JG. 1997. Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine régulation of cell volume. J Biol Chem 272:21970-21976.
53. Schwiebert EM, Egan ME, HwangT-H, Fulmer SB, Allen SS, Cutting GR, Guggino WB. 1995. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATE Cell 81:1063-1073.
54. Steinberg TH, Silverstein SC. 1987. ATP4" penneabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem 262:8884-8888.
55. Suprenant A, Rassendren F, Kawashima E, North RA, Buell G. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735-738.
56. Wiley JS, Chen R, Jamieson GE 1993. The ATP1' receptor-operated channel (P2Z class) of human lymphocytes allows Ba + and ethidium uptake: inhibition of fluxos by suramin. Arch Biochem Biophys 305:54-60.
57. Wiley JS, Dubyak GR. 19S9. Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes. Blood 73:1316-1323.
58. Wolf N. 1998. Pathology: basic and systemic. London: Saunders Company Ltd.
59. Zimmermann H. 1996. Extracellular purine metabolism. Dnig Dev Res 39:337-352.